Literature DB >> 6368780

Impaired natural killer activity in lymphohistiocytosis syndrome.

N Perez, J L Virelizier, F Arenzana-Seisdedos, A Fischer, C Griscelli.   

Abstract

In six patients with well-documented lymphohistiocytosis syndrome, natural killer activity was found to be profoundly impaired and could not be increased by incubation in vitro with interferon. This abnormality was not found in parents of the affected children. A clear correlation with the activity of the disease was observed, although a delay of a few weeks (possibly reflecting the life span of NK cells in blood) was seen in the disappearance of NK activity after the onset of the disease and its reappearance after remission. No absolute correlation was observed between NK activity and percentage of leukocytes detected by the Leu-7 monoclonal antibody. Our findings indicate that testing NK activity is useful for the diagnosis of lymphohistiocytosis syndrome and can be used as an index of activity of the disease, among other major clinical and biologic signs of this syndrome. Reversal of the NK activity defect (rather than detection of Leu-7 positive cells) appears to be a good criterion of complete remission.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368780     DOI: 10.1016/s0022-3476(84)80549-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Molecular basis of familial hemophagocytic lymphohistiocytosis.

Authors:  Valentina Cetica; Daniela Pende; Gillian M Griffiths; Maurizio Aricò
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  Peripheral neuropathy associated with erythrophagocytic lymphohistiocytosis.

Authors:  B Boutin; M C Routon; F Rocchiccioli; M Mayer; G Leverger; O Robain; G Ponsot; M Arthuis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

3.  Unusual immunophenotype displayed by histiocytes in haemophagocytic lymphohistiocystosis.

Authors:  T Herlin; G Pallesen; T Kristensen; N Clausen
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

4.  Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis.

Authors:  A Santoro; S Cannella; G Bossi; F Gallo; A Trizzino; D Pende; F Dieli; G Bruno; J C Stinchcombe; C Micalizzi; C De Fusco; C Danesino; L Moretta; L D Notarangelo; G M Griffiths; M Aricò
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

Review 5.  Histiocytoses.

Authors:  J L Stéphan
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

6.  Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.

Authors:  M Aricò; L Nespoli; R Maccario; D Montagna; F Bonetti; D Caselli; G R Burgio
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

7.  Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis.

Authors:  Russell W Jenkins; Christopher J Clarke; John Thomas Lucas; Munira Shabbir; Bill X Wu; Fabio Simbari; Joan Mueller; Yusuf A Hannun; John Lazarchick; Keisuke Shirai
Journal:  Am J Hematol       Date:  2013-08-30       Impact factor: 10.047

8.  Familial hemophagocytic lymphohistiocytosis associated with disseminated T-cell lymphoma: a report of two siblings.

Authors:  C J Mache; I Slavc; C Schmid; G Hoefler; C E Urban; W Schwinger; E Winter; W Hulla; W Zenz; W Holter
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

9.  A prospective study of CD45 isoform expression in haemophagocytic lymphohistiocytosis; an abnormal inherited immunophenotype in one family.

Authors:  R Wagner; G Morgan; S Strobel
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

Review 10.  Familial hemophagocytic lymphohistiocytosis: clinical and neuroradiological findings and review of the literature.

Authors:  Norma Decaminada; Maria Cappellini; Marzia Mortilla; Erica Del Giudice; Elena Sieni; Desireè Caselli; Maurizio Aricò; Claudio Fonda
Journal:  Childs Nerv Syst       Date:  2009-08-01       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.